| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Endoscopic ultrasound-guided ablation of solid pancreatic lesions: A systematic review of early outcomes with pooled analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Marco Spadaccini, Milena Di Leo, Andrea Iannone, Daan von den Hoff, Alessandro Fugazza, Piera Alessia Galtieri, Gaia Pellegatta, Roberta Maselli, Andrea Anderloni, Matteo Colombo, Peter D Siersema, Silvia Carrara and Alessandro Repici |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Silvia Carrara, MD, Doctor, Doctor, Professor, Endoscopy unit, Humanitas Research Hospital, Via manzoni 56, Rozzano 20089, Italy. silvia.carrara@hunimed.eu |
| Key Words |
Pancreatic cancer; Neuroendocrine tumours; Habib; Cryotechnology; Pancreas; Endoscopic ultrasound |
| Core Tip |
Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is emerging as a complementary therapeutic approach for pancreatic solid masses. However, results of published data are difficult to interpret because of a retrospective design and small sample size. Pooling results across 14 published experiences, the technical success rate was 99.0% among over 150 ablations, with an overall adverse event (AE) rate of 8.0%. Excluding mild AEs, the pooled rate of serious AEs was 1.0%, with no mortality. The present pooled analysis confirms the feasibility and safety of EUS-RFA. |
| Publish Date |
2022-02-10 14:26 |
| Citation |
Spadaccini M, Di Leo M, Iannone A, von den Hoff D, Fugazza A, Galtieri PA, Pellegatta G, Maselli R, Anderloni A, Colombo M, Siersema PD, Carrara S, Repici A. Endoscopic ultrasound-guided ablation of solid pancreatic lesions: A systematic review of early outcomes with pooled analysis. World J Gastrointest Oncol 2022; 14(2): 533-542 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i2/533.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i2.533 |
